Literature DB >> 28233289

Hyperbaric oxygen therapy for chronic ulcers in systemic sclerosis - case series.

Bengusu Mirasoglu1, Bekir S Bagli1, Samil Aktas1.   

Abstract

BACKGROUND: Digital and leg ulcers are extremely painful, hard to heal manifestations of systemic sclerosis (SSc). Many treatments have been tried for these challenging complications, but use of hyperbaric oxygen therapy (HBOT) is very limited. HBOT has been used as an adjunctive therapy for treating chronic wounds, and nonhealing SSc wounds, which have a hypoxic nature, may also benefit from it.
METHODS: This is a retrospective analysis of six SSc patients who underwent HBOT for their ulcers. Patient demographics, ulcer properties, and details of treatments were evaluated.
RESULTS: Three patients had digital ulcers, and the other three had leg ulcers. Three patients (two leg ulcers and one digital ulcer) had bilateral lesions. All patients had been treated for at least one and a half months with various modalities. After HBOT was applied, four patients' ulcers healed completely and two patients had near-complete healing. Amputation was not required for any.
CONCLUSION: This case series, which has the largest patient population up to present, shows adjunctive HBOT may be helpful in the treatment of SSc ulcers.
© 2017 The International Society of Dermatology.

Entities:  

Mesh:

Year:  2017        PMID: 28233289     DOI: 10.1111/ijd.13570

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  2 in total

1.  Locoregional Treatments for Digital Ulcers in Systemic Sclerosis: A Systematic Review.

Authors:  Ingrid Costedoat; Maeva Masson; Thomas Barnetche; Pierre Duffau; Estibaliz Lazaro; Christophe Richez; Julien Seneschal; Marie-Elise Truchetet
Journal:  Acta Derm Venereol       Date:  2021-06-22       Impact factor: 3.875

2.  Systemic sclerosis-related digital calcinosis; a pilot study of cutaneous oxygenation and perfusion.

Authors:  Elizabeth Marjanovic; Tonia L Moore; Joanne B Manning; Graham Dinsdale; Sarah Wilkinson; Mark R Dickinson; Ariane L Herrick; Andrea K Murray
Journal:  Rheumatology (Oxford)       Date:  2020-11-01       Impact factor: 7.580

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.